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The objective of the present study was to investigate the effects of starches with differing rates of hydrolysis on exposure to pancreatin in
vitro on postprandial carbohydrate metabolism in healthy subjects and in subjects with type 2 diabetes. Two test starches, prepared from
uncooked native granular starch products, and naturally enriched with 13C, were consumed in a randomized crossover design by eight
healthy and thirteen type 2 diabetic subjects. One starch was characterized in vitro as being rapidly hydrolysed (R, 94 % after
180 min), and the other was more slowly hydrolysed (S, 51 % after 180 min). Each subject consumed 50 g of each test starch. In addition,
the type 2 diabetic subjects consumed 89·7 g of the S starch on a separate occasion. Blood samples were taken at 10 min intervals for 3 h,
and at 20 min intervals for a further 3 h during a 6 h postprandial period. Breath 13CO2 enrichment was measured at the same time points,
and indirect calorimetry was performed for seven 20 min sessions immediately before and during the 6 h postprandial period. With the R
starch, plasma glucose concentrations and serum insulin concentrations rose faster and the maximum glucose change was approximately
1·8 times that for the S starch, averaged across both subject groups. The areas under the curves for glucose and insulin were, respectively,
1·7 and 1·8 times higher for the R starch compared with the S starch, averaged across both subject groups. The rate of 13CO2 output and the
proportion of 13C recovered in breath after consumption of the R starch was similar for both subject groups. The results provide evidence
that starches which have different rates of hydrolysis in vitro result in different patterns of glycaemia and insulinaemia in both healthy
adults and in diet-controlled type 2 diabetic subjects. Data from the hydrolysis of novel starch products in vitro, therefore, are useful
in predicting glycaemic responses in vivo.
Starch digestion: Glycaemia: Insulinaemia: In vitro starch hydrolysis: Diabetes
For the maintenance of health and prevention of several
common non-communicable diseases in adults, the recent
FAO/WHO Expert Consultation (Food and Agriculture
Organization/World Health Organization, 1998) rec-
ommended: ‘that energy balance be maintained by consum-
ing a diet containing at least 55 % of total energy from
carbohydrate from various sources. . .’. The recommen-
dation underlines the importance of starchy foods derived
from cereals, tubers and roots in healthy diets and empha-
sizes the diversity of metabolic and health responses to
different food carbohydrates. A key component of these
metabolic responses is the rate and extent of glucose absorp-
tion with corresponding requirements for insulin secretion.
Sub-optimal glucose tolerance and insulin insensitivity
appear to play important roles in the aetiology of diabetes
and cardiovascular disease (Reaven, 1995) and may be
modulated by dietary carbohydrate consumption patterns
(Daly et al. 1997; Mathers & Daly, 1998). The amount of
dietary carbohydrate in the diet and the rate and extent of
digestion of this carbohydrate are the principal determinants
of postprandial glucose and insulin responses (Wolever &
Bolognesi, 1996; Wolever, 2000). Predicting these
responses, however, has proved difficult. Prediction relies
upon a combination of in vitro procedures to classify carbo-
hydrates according to their rate of hydrolysis and release of
glucose (Englyst et al. 1992, 1996, 1999; A˚kerberg et al.
1998), and in vivo measurement of glycaemic index (GI)
(Jenkins et al. 1981, 2002; Wolever & Jenkins, 1986;
Bornet et al. 1989; Wolever, 2000). In addition, studies
using carbohydrates labelled with stable isotopes have
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been used to make direct comparisons between in vitro rates
of hydrolysis and glycaemic response in human subjects
(Normand et al. 1992; Vonk et al. 2000) and pigs (Noah
et al. 2000).
Recent advances in the understanding of the roles of
starches in health have identified the need to develop
food starches which differ in their rate and extent of diges-
tion in the small intestine (Wolever, 1991; Jenkins et al.
2002). Consumption of these starches may help in the man-
agement of diabetes through reduction in the excursions in
plasma glucose and insulin concentrations. Such slowly
digested starchy foods may be of wider benefit in reducing
the risk of some common non-transmissible diseases in the
general public. Incorporation of appropriately character-
ized starches into foods may provide a palatable and accep-
table way of eating slowly digestible starches. The aim of
the present series of studies was to investigate the effects
of two contrasting uncooked native granular starches,
naturally enriched with 13C and with differing rates of
hydrolysis in vitro, on postprandial glycaemia and insuli-
naemia in normal healthy adults and in subjects with
type 2 (non-insulin-dependent) diabetes.
Materials and methods
Subjects
The experimental protocol for the present study was
approved by the joint ethics committees of Newcastle and
North Tyneside Health authorities, University of Newcastle
upon Tyne, and University of Northumbria at Newcastle.
Each subject gave his or her informed, written consent to
participate. All studies were conducted in the Wellcome
Research Laboratories, Royal Victoria Infirmary, Newcastle
upon Tyne, UK.
Eight healthy, weight-stable volunteers (four male and
four female) were recruited from the student and staff popu-
lations of the University of Newcastle upon Tyne and from
staff of the Royal Victoria Infirmary, Newcastle upon Tyne.
None had diabetes mellitus (or a first-degree relative with
diabetes), IHD, hypertension, or any other disease associ-
ated with altered insulin sensitivity. None were taking any
drugs known to alter insulin sensitivity or to affect carbo-
hydrate or lipid metabolism. All were non-smokers.
Thirteen volunteers (nine male and four female) diag-
nosed with type 2 diabetes controlled by diet alone were
recruited using the patient database in the Newcastle
upon Tyne Diabetes Centre, Newcastle General Hospital,
Newcastle upon Tyne. Exclusion criteria for recruitment
included: poor diabetes control (glycated haemoglobin
.8·5 %); major complications of diabetes; use of sulfony-
lurea or a-1-glucosidase inhibitor therapy; a BMI . 30 kg/
m2 recorded in the patient’s hospital notes.
The experimental starches
The experimental starches were uncooked native granular
starches not derived via genetic engineering or by chemical
modification, and were provided by the National Starch
and Chemical Company (Bridgewater, NJ, USA). Raw
starches were chosen to investigate whether starches with
different rates of digestion in vitro result in different phys-
iological responses in vivo. Although not common in the
diet, raw starches are eaten by human consumers; for
example, in muesli, and raw maize starch is currently
used in minimally processed products for diabetics, and
is recommended for patients with certain forms of glyco-
gen storage disease. To the authors’ knowledge, the
starches used in the present study have not been investi-
gated in this way before. In vitro hydrolysis of the test
starches was determined as follows. Starch (2 g) was
mixed with 40 ml phosphate buffer (0·05 M, pH 6·9;
0·68 M-NaCl) and equilibrated at 378C. At time zero, 5 %
(w/v) pancreatin (8 ml) (Sigma, catalogue no. P-7545; St
Louis, MO, USA) in phosphate buffer was added to the
starch suspension. Samples (1·5 ml) of the digestion mix-
ture were removed at 10 min intervals for 60 min, 20 min
intervals for the next 120 min and at 60 min intervals there-
after to a total of 360 min into microcentrifuge tubes and
centrifuged for 2 min at 9000 g (Fischer Scientific Micro-
centrifuge 59V; Pittsburgh, PA, USA). After enzymic
digestion the hydrolysis products in the supernatant frac-
tion were measured as percentage solubles using a Fischer
Handheld Refractometer (Fischer Scientific; Pittsburgh,
PA, USA) with a Brix scale that had been zeroed with dis-
tilled water. The Brix scale measures sugar concentrations
in solutions. The percentage solubles value was then con-
verted to percentage starch digested by accounting for
the percentage solubles contributed by all components
before incubation, as well as the initial weight of starch
digested. As a further comparison of the test starches, the
resistant starch content of each product was determined
using the procedure described by Englyst et al. (1992),
with additional measurements of starch remaining at
360 min. The test starches were the rapidly hydrolysed
(R) starch AMIOCAe, and the slowly hydrolysed (S)
NUTRA-STARCHe. These were presented as pre-
weighed samples with a sweetened orange flavouring in
screw-topped plastic containers (colour coded) suitable
for reconstituting the suspensions immediately before use
in each study. The 13C content of the starches, determined
by isotope ratio MS, was higher for the R starch than for
the S starch (1·0993 v. 1·0920 atoms percent). The R
starch is a single-component waxy maize-derived starch
(,1 % protein, ,1 % fibre, and .99 % carbohydrate
with an amylopectin composition .98 %). The S starch
is composed of a blend of tapioca and maize starch in
the proportion of 46:54 (,1 % protein, ,2 % fibre and
.99 % carbohydrate with an amylopectin content of at
least 80 %). The tapioca starch is essentially ‘unlabelled’
since this component is derived from a non-C4 plant.
Since this component of the S starch is ‘invisible’ using
the 13C enrichment approaches, the quantification of
oxidation of exogenous glucose has been restricted to the
R starch.
Experimental protocol: healthy subjects
Each subject (n 8) took part in two experimental periods in
a randomized, double-blind, crossover design. Subjects
were admitted at 07.45 hours, having fasted from 21.00
hours the previous evening. Alcohol and strenuous exercise
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were avoided for 24 h before each experimental period.
Study periods were separated by a minimum of 1 week
(males and post-menopausal females), with 1 month for
menstruating females to keep as close as possible to a
fixed point in the menstrual cycle. After consumption of
50 g of each test starch suspended in 250 ml cold water,
blood samples were taken over a 6 h period from a retro-
grade cannula in a dorsal hand vein at 10 min intervals
for 3 h, and then at 20 min intervals for the next 3 h. The
cannula was inserted 15 min before baseline samples
were taken, and the hand was kept in a heated box at
558C to facilitate arterial blood sampling. Breath samples
were taken at the same time as blood samples and indirect
calorimetry measurements were made using a Deltatrac
Indirect Calorimeter (Datex Instrumentarium Corporation,
Helsinki, Finland) for 20 min at 40 min intervals from
time 220 min to time 100 min and then for 20 min at
60 min intervals until the end of the 6 h study period.
Starch suspensions were consumed within 3 min, and
volunteers were allowed unlimited access to drinking
water throughout the experimental period.
Experimental protocol: type 2 diabetic subjects
Each subject (n 13) took part in two experimental periods in
a randomized, double-blind, crossover design as described
for healthy subjects except that in addition they were pro-
vided with a standard meal for consumption the evening
before each experimental study day in an attempt to
reduce variability in fasting blood glucose concentrations.
The energy content of the meal was approximately 2·2 kJ,
with 38 % energy from fat, 47 % energy from carbohydrate,
and 15 % energy from protein. Eleven of the thirteen sub-
jects (eight male, three female; two subjects were with-
drawn from the study for unrelated health reasons) took
part in a third study of similar design in which the dose of
the S starch was increased in an attempt to mimic the
glycaemic response to the lower dose of the R starch. The
period between the second and third experimental days
averaged 10·7 weeks. The quantity of starch consumed in
the third experimental period was calculated using the incre-
mental area under the curve (IAUC) as follows:
50 £ IAUC for the R starch
IAUC for the S starch
 
:
The ratio of the areas under the glucose curve for the R and
S starches (1·794:1, equivalent to 87·9 g S starch) from
eleven of the thirteen diabetic subjects (those who had com-
pleted the study at the time of the calculation) was used in
the calculation. Volunteers consumed the larger mass of
the S starch suspended in 250 ml water, but were asked to
drink a further 150–200 ml water after consuming the
starch to maintain a similar starch:water value to that used
in the earlier studies.
Analytical methods
Plasma glucose, non-esterified fatty acids (NEFA) and
serum insulin concentrations were determined using
standard enzymic procedures as described previously
(Daly et al. 1998, 2000). Enrichment of 13CO2 in breath
and the enrichment of 13C in the test starches were deter-
mined by isotope ratio MS using an ANCA 20:20 mass
spectrometer (Europa Scientific, Crewe, Ches., UK).
Habitual dietary intake of subjects and anthropometric
measurements
The subjects’ habitual food intakes were estimated from a
7 d food record collected before the clinical study days and
food portion sizes were quantified with the aid of a food
atlas (Nelson et al. 1997) and face-to-face interview with
the subjects on completion of the record. Nutrient intakes
were calculated from food records using an Integrated
Dietary Analysis program (IDA Publications, London,
UK). The food record was validated by comparing esti-
mated food N intake with 24 h urinary N excretion and
the completeness of the urine collection was assessed
through urinary recovery of a 240 mg oral dose of p-amino-
benzoic acid (Bingham & Cummings, 1983).
Percentage body fat was calculated by the equations of
Siri (1956) from estimates of body density derived from
skinfold thickness measurements (using a Holtain–
Tanner and Whitehouse skin calliper; Holtain, Crosswell,
Pembrokeshire, UK) made over the triceps muscle
(Durnin & Womersley 1974).
Calculations and statistical analysis
The IAUC for plasma glucose response was calculated
using the difference between plasma glucose concentration
at baseline and each time point using a standard trapezoid
procedure (Food and Agriculture Organization/World
Health Organization, 1998). Since serum insulin concen-
trations are not normally distributed, the IAUC for serum
insulin was calculated using similar trapezoid procedures
using log-transformed data followed by back-transform-
ation for presentation of the results. The incremental area
over the curve for the plasma NEFA response was calcu-
lated using the difference between the plasma NEFA con-
centration at baseline and each time point using the same
trapezoid procedure. The rate of excretion of 13C as
13CO2 in breath was calculated as the product of
13CO2
enrichment (atoms percent above background) and CO2
production (determined by indirect calorimetry at each
time point during the experimental period) as described
previously (Daly et al. 2000). The cumulative output of
13C over the 360 min experimental period was calculated
from the IAUC for 13CO2 output and expressed as a
percentage of the original dose above background for
each individual. Carbohydrate and fat oxidation rates,
and oxidation of exogenous carbohydrate were calculated
from indirect calorimetry data and 13CO2 enrichment as
described by Jeukendrup et al. (1997).
Statistical analysis was carried out using SPSS for Win-
dows (SPSS Inc., Chicago, IL, USA). All data within each
study were examined using two-tailed paired t tests. Differ-
ences between data for healthy and type 2 diabetic subjects
were compared by ANOVA. Data are presented as mean
values and standard deviations.
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Results
In vitro starch hydrolysis
The two starches demonstrated contrasting hydrolysis
characteristics (Fig. 1). The hydrolysis of the R starch,
extracted from waxy maize, was initially very rapid with
approximately 94 % of the starch hydrolysed after
180 min. The rate of hydrolysis decreased thereafter with
approximately 96 % hydrolysed after 360 min. In contrast,
the S starch, a combination of tapioca and maize starches,
was more slowly hydrolysed with only 51 % hydrolysis
after 180 min, and approximately 68 % hydrolysed after
360 min. When determined using the method described
by Englyst et al. (1992), the resistant starch content of
the test starches at 120 min was 11·2 and 31·8 %, respect-
ively for the R and S starch. Further measurements of
starch remaining at 360 min were 0·0 and 15·0 %, respect-
ively for the R and S starch. These observations confirmed
the present study’s predictions that the R starch would be
rapidly hydrolysed, and that the combination of starches
in the S starch would be more slowly hydrolysed.
Subject characterization
The healthy volunteers for the present study were, on aver-
age, slightly younger and approximately 10 kg lighter
(P¼0·054) than the type 2 diabetic volunteers but otherwise
the two groups were of similar BMI and body composition
(Table 1). Fasting plasma cholesterol concentrations were
similar for both groups, but the plasma triacylglycerol con-
centration of the diabetic group was significantly higher
than that of the healthy group (Table 1). The habitual dietary
intake data suggested that the mean intakes of carbohydrates
and fat (Table 2) were similar to those reported for the adult
population of the UK (Gregory et al. 1994). In both subject
groups, men consumed a higher proportion of energy as
alcohol but a lower proportion as carbohydrates than did
women. Comparison of reported energy intakes with calcu-
lated BMR gave physical activity levels of 1·6 and 1·5 for
the healthy subjects and diabetics, respectively, well
within accepted ranges for accurate recording of dietary
intake (Goldberg et al. 1991). Urine collections over 24 h
were judged to be complete on the basis of p-aminobenzoic
acid recovery (Bingham & Cummings, 1983). Both the esti-
mates of physical activity level and reported N intake:urin-
ary N output values indicated that the self-reported food
consumption data may be considered as reliable estimates
of habitual intake (Bingham & Cummings, 1985; Goldberg
et al. 1991).
Plasma metabolite responses with 50 g of the test starches
Fasting plasma glucose concentrations were 5·36 (SD 0·425)
and 6·88 (SD 1·737) mM for the healthy subjects and type 2
diabetic subjects, respectively. Fasting plasma insulin con-
centrations were 6·26 (SD 1·89) and 23·5 (SD 34·94) pM for
the healthy subjects and type 2 diabetic subjects, respect-
ively. There were no significant differences between study
days for either group for glucose or insulin. There were
marked differences in the postprandial plasma glucose and
serum insulin profiles between the test starches and between
the healthy volunteers and type 2 diabetic subjects (Figs. 2
and 3). With the R starch, plasma glucose rose more rapidly
to a higher peak (maximum glucose change) than after con-
suming the S starch when the glucose response was slower
and more sustained (Table 3). For the healthy subjects,
plasma glucose concentrations fell slightly below fasting
values from approximately 210 min after consuming the
R starch and reached fasting values approximately
270 min after consuming the S starch. This is in contrast
with the results for the type 2 diabetic subjects in whom
the plasma glucose response was, on average, greater and
more sustained than that seen for the healthy subjects.
In addition, for the diabetic subjects, the plasma glucose
concentration reached fasting values after approximately
220–260 min and then continued to fall throughout the
measurement period. The area under the glucose curve
was higher for the R starch compared with the S starch for
both subject groups but significantly so (P,0·05) for the
diabetics only. The pattern of serum insulin response was
similar to that observed for glucose except for a less
pronounced fall below baseline concentrations in the late
postprandial period with the diabetic subjects.
The plasma NEFA concentrations of the healthy subjects
fell rapidly after consuming both starches and reached
lower concentrations in subjects consuming the R starch
compared with the S starch (0·02 v. 0·08 mM; P¼0·05 for
the R and S starches, respectively). The response in the
type 2 diabetics was similar, but the fall was less rapid
and the lowest concentration was higher than that observed
Fig. 1. Percentage of starch hydrolysis assessed in vitro (n 4) for
rapidly hydrolysed (O) and slowly hydrolysed (B) starch. Values are
means, with standard errors of the mean represented by vertical
bars. For details of procedures, see p. 854.
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for the healthy subjects (0·12 v. 0·18 mM for the R and S
starches, respectively; Table 3), although this difference
was not statistically significant. From approximately 90–
150 min after consuming the test starches, plasma NEFA
concentrations remained low for 2–3 h before rising
above baseline values by the end of the measurement
period. During this late postprandial period, the plasma
NEFA concentration was higher after consuming the R
starch than the S starch in both subject groups. The area
over the curve, measured over 360 min, was similar for
both starches and for both subject groups (overall mean
286 mM £ min; Table 3). A similar pattern was observed
for plasma 3-hydroxybutyrate concentrations, which fell
rapidly from fasting concentrations of 0·09 (SD 0·06) and
0·11 (SD 0·094) mM in the healthy subjects and type 2
diabetic subjects, respectively, after consuming the test
starches. The plasma concentrations of this metabolite
rose more rapidly during the late postprandial period fol-
lowing the consumption of the R starch in both subject
groups. For the healthy subjects, the 3-hydroxybutryate
concentration at 360 min was 0·32 (SD 0·31) mM for the
R starch and 0·19 (SD 0·18) mM for the S starch
(P¼0·356). For the type 2 diabetic subjects, the 3-hydroxy-
butyrate concentration at 360 min was similar to that seen
in the healthy subjects after consuming the R starch. How-
ever, the 3-hydroxybutyrate concentration was significantly
higher (P,0·05) than for both doses of the S starch (0·32
(SD 0·30) mM compared with 0·10 (SD 0·10) and 0·05 (SD
0·07) mM for 50 and 87·9 g, respectively).
Plasma metabolite responses with 89·7 g slowly hydrolysed
starch in diabetic subjects
Increasing the quantity of the S starch consumed to 89·7 g
resulted in an increase in the maximum glucose change to
2·63 mM. This was lower than but not significantly different
from that observed following 50 g R starch (P.0·40), and
although numerically higher than that observed for the
Table 1. Anthropometric characteristics and fasting plasma lipid concentrations of the volunteers
(Mean values and standard deviations)
Healthy subjects Diabetic subjects
Males (n 4) Females (n 4) Overall (n 8) Males (n 9) Females (n 4) Overall (n 13)
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Age (years) 39·5 15·9 48·5 10·2 44·1 13·4 56·7 8·1 44·3 3·7 52·9 9·1
Body weight (kg) 79·2 5·6 63·3 12·3 71·2 12·3 79·7 10·9 85·7 10·1 81·6 10·6
BMI (kg/m2) 25·6 1·5 24·3 3·2 25·9 1·5 26·4 2·3 32·6 3·4 28·3 3·9
Fasting total cholesterol (mmol/l) 4·89 0·47 4·89 0·38 4·89 0·39 4·83 0·57 4·33 1·15 4·67 0·78
Fasting HDL-cholesterol (mmol/l) 1·31 0·20 1·63 0·49 1·47 0·39 1·26 0·31 1·03 0·25 1·18 0·30
Fasting LDL-cholesterol (mmol/l) 3·09 0·30 2·79 0·23 2·94 0·29 2·89 0·69 2·53 0·38 2·78 0·70
Fasting triacylglycerol (mmol/l) 1·10 0·21 1·03 0·43 1·06 0·32 1·53 0·35 1·70 0·93 1·59* 0·55
Hb1Ac (% total haemoglobin) – – – – 6·92 0·76 5·85 0·33 6·59 0·82
Time since diagnosis (months) – – 91 72 105 57 96 65
Waist:Hip 0·89 0·05 0·74 0·06 0·82 0·09 0·92 0·05 0·81 0·03 0·88 0·07
Percentage body fat 29·2 4·8 37·4 3·1 33·3 5·8 28·3 4·7 39·8 2·1 31·8 6·8
Hb1Ac, glycated haemoglobin.
* Mean value was significantly different from that for the healthy subjects (P,0·025).
Table 2. Habitual daily energy and nutrient intakes of the volunteers*
(Mean values and standard deviations)
Healthy subjects Diabetic subjects
Males (n 4) Females (n 4) Overall (n 8) Males (n 9) Females (n 4) Overall (n 13)
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Energy (MJ) 11·8 2·3 8·9 0·5 10·4 2·2 11·9 2·6 8·7 4·6 10·9 3·5
Fat (% energy) 34·3 6·1 40·5 4·1 37·4 5·9 36·2 6·3 33·9 8·3 35·5 6·7
Total carbohydrate
(% energy)
38·5 5·1 44·5 5·1 41·5 5·7 41·8 7·1 48·4 7·8 43·8 7·6
Protein (% energy) 15·0 2·9 12·8 1·3 13·9 2·4 15·7 3·8 17·5 4·7 16·3 3·9
Alcohol (% energy) 12·0 2·8 2·3 2·2 7·1 5·7 6·3 9·1 0·5 0·9 4·5 7·9
Calculated BMR† (MJ/d) 7·06 0·44 5·30 0·32 6·52 1·04 7·23 0·65 6·45 0·34 6·99 0·67
Physical activity level‡ 1·59 0·28 1·59 0·17 1·59 0·22 1·56 0·35 1·33 0·32 1·49 0·45
Percentage recovery PABA§ 104·8 5·4 98·3 8·4 101·5 7·4 83·4 13·5 86·9 5·7 84·3 11·6
Urinary N/N intakek 0·79 0·10 0·80 0·06 0·80 0·08 0·94 0·15 0·92 0·30 0·93 0·19
PABA, p-aminobenzoic acid.
* For details of subjects and procedures, see Table 1 and p. 854.
† Calculated BMR from Schofield equations (Department of Health, 1991).
‡ Reported energy intake/calculated BMR.
§ Oral marker recovered in urine as a measure of completeness of urinary collection (Bingham and Cummings, 1983).
kBased on average reported N intake on the day before and the day of urine collection.
Starch digestion and carbohydrate metabolism 857
lower dose of the S starch, was not significantly different
from this value (P¼0·117; Table 3). Consumption of
89·7 g S starch resulted in a similar decrease in plasma
NEFA concentrations to that observed with 50 g S starch,
but the nadir was achieved later, and was sustained
throughout the study period. Plasma 3-hydroxybutyrate
concentrations were also lower at the end of the study
period than those observed after consuming 50 g S starch.
13C metabolism
13CO2 output in breath (Fig. 4) was determined as a
measure of oxidation of glucose absorbed from the R
starch, which was naturally enriched with 13C. Breath
13CO2 output was similar for the healthy and type 2 dia-
betic subjects for about the first 230–270 min. Thereafter,
rates of breath 13CO2 output fell for the healthy subjects
whilst rates remained approximately constant for the
diabetic subjects until very late in the study period.
Because the background enrichment of breath 13CO2 was
slightly lower for the diabetic than for the healthy subjects,
apparent 13C dose was higher for the former subjects
(Table 4). There were no between-subject group differ-
ences in either the total 13C recovered in breath or the per-
centage administered dose recovered up to 360 min after
the test meal (Table 4).
Fig. 2. (a), Change from baseline in plasma glucose concentrations after consumption of 50 g rapidly hydrolysed (O) and 50 g slowly hydro-
lysed (B) starch for healthy subjects (n 8); (b), change from baseline in plasma glucose concentrations after consumption of 50 g rapidly hydro-
lysed starch (O; n 13), 50 g slowly hydrolysed starch (B; n 13) and a higher dose (89·7 g) of slowly hydrolysed starch (A; n 11) for subjects
with type 2 diabetes. Values are means, with standard errors of the mean represented by vertical bars. For details of subjects and procedures,
see Table 1 and p. 854.
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Quantification of carbohydrate and lipid oxidation
From measurements of O2 consumption and CO2
production over the study period, cumulative rates of
carbohydrate and lipid oxidation have been calculated
and are shown in Table 5. Incremental changes in rates
of carbohydrate oxidation above baseline and lipid oxi-
dation below baseline values are shown in Fig. 5. Figs. 5
(a) and (b) show that the increase in carbohydrate oxidation
after consuming the test starches was similar for the
healthy subjects for both starches but was reduced in the
diabetic subjects consuming the S starch compared with
the R starch. The incremental area over the curve was
7·43 g/180 min for the R starch compared with 1·58 g/
180 min for the S starch (P,0·05). Lipid oxidation was
reduced following the consumption of the test starches
(Figs. 5 (c) and (d)) and, although not statistically signifi-
cant, was reduced more after the R starch compared with
the S starch in both subject groups. Oxidation of exogenous
carbohydrate, determined from indirect calorimetry and
13CO2 output measurements after consumption of the R
starch, was similar for both subject groups. However,
when expressed as a percentage of total carbohydrate oxi-
dation, exogenous carbohydrate oxidation was significantly
lower for the diabetic subjects compared with the healthy
subjects (10·0 v. 13·3 %; P,0·05).
Discussion
The rate and extent of starch digestion in the small
intestine play important roles in determining glycaemic
Fig. 3. (a), Change from baseline in plasma insulin concentrations after consumption of 50 g rapidly hydrolysed (O) and 50 g slowly hydrolysed
(B) starch for healthy subjects (n 8); (b), change from baseline in plasma insulin concentrations after consumption of 50 g rapidly hydrolysed
starch (O; n 13), 50 g slowly hydrolysed starch (B; n 13) and a higher dose (89·7 g) of slowly hydrolysed starch (A; n 11) for subjects with type
2 diabetes. Values are means, with standard errors of the mean represented by vertical bars. For details of subjects and procedures, see
Table 1 and p. 854.
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and insulinaemic responses following a meal and are
affected by the source and degree of processing during
food preparation (Food and Agriculture Organization/
World Health Organization, 1998; Mathers & Daly,
2001). Several methods are available for the classification
of starches, based both on their in vitro hydrolysis under
a variety of incubation conditions and their digestion in
vivo. For example, the extent of glucose release from
starch hydrolysis under carefully defined conditions forms
the basis of a current proposal for classification of starch
fractions including rapidly digestible starch, slowly digesti-
ble starch and resistant starch (Englyst et al. 1992). These
components are included with other dietary carbohydrate
sources (free sugars and maltodextrins) when considering
the potential availability of glucose from foods in the
small intestine as either rapidly available glucose or
slowly available glucose (Englyst et al. 1999). Diets
which contain large amounts of rapidly digested carbo-
hydrates result in elevated blood glucose and insulin
responses, which are risk factors for increased insulin resist-
ance and the development of type 2 diabetes (Salmero´n
et al. 1997a,b). In contrast, diets which contain large
amounts of carbohydrates resistant to small-intestinal diges-
tion and which deliver starch to the large bowel may protect
against such conditions and also against other non-
communicable diseases including colon cancer (Cassidy
et al. 1994; Hylla et al. 1998).
The usefulness of in vitro data in predicting in vivo
responses in human subjects remains uncertain. Englyst
et al. (1999) have suggested that the assessment of rapidly
available glucose using an in vitro hydrolysis procedure
was a good indicator of blood glycaemic response. To
date, probably the most extensively investigated method
for predicting glucose response is the measurement of
GI, and lists of GI exist for a wide range of foods
(Foster-Powell & Brand-Miller, 1995). However, this
requires experimentation with human volunteers and the
Table 4. 13C dose and recovery in breath carbon dioxide of sub-
jects following consumption of 50 g rapidly hydrolysed starch*
(Mean values and standard deviations)
Healthy
subjects (n 8)
Diabetic
subjects (n 13)
Mean SD Mean SD
13C dose (mg above
background)
3568a 122 3758b 214
13C recovered in
breath (mg/360 min)
1000a 209 957a 259
Recovery of 13C dose
after 360 min (%)
28·1a 5·9 25·4a 6·7
a,b Mean values with unlike subscript letters within a row were significantly
different (P,0·05).
* For details of subjects and procedures, see Table 1 and p. 854.
Table 3. Derived parameters of plasma glucose and insulin responses for subjects following consumption of test starches*
(Mean values and standard deviations)
Healthy subjects Diabetic subjects
50 g
R starch (n 8)
50 g
S starch (n 8)
50 g
R starch (n 13)
50 g
S starch (n 13)
89·7 g
S starch (n 11)
Mean SD Mean SD Mean SD Mean SD Mean SD
Maximum glucose
change (mM)
2·45a 0·86 1·29b 0·38 3·12a 0·85 1·78b,c 1·00 2·63a,c 1·20
Time to glucose
peak (min)
55a 20·0 61a 10·8 77a 20·5 84a 26·9 96a 21·1
IAUC for glucose
(mM £ min)
205a 85·9 134a 62·7 366a 99 191b 132 302a 157
IAUC for insulin
(mU/l £ min)
2192a 488 1150b 405 2859a 1572 1640a 1279 2334a 1627
Minimal plasma NEFA
concentration (mM)
0·02a 0·03 0·08b 0·12 0·12a 0·07 0·18a 0·15 0·15a 0·16
Time to NEFA
minimum (min)
93a 29 103a 17 138a 18 146a 53 170a 38
IAOC, for NEFA
(mM £ min)
292a 42 293a 55 285a 21 275a 29 287a 46
R, rapidly hydrolysed; S, slowly hydrolysed; IAUC, incremental area under the curve; NEFA, non-esterified fatty acids; IAOC, incremental area over the curve.
a,b,cMean values with unlike subscript letters within a row, within each subject group, were significantly different (P,0·05).
* For details of subjects and procedures, see Table 1 and p. 854.
Fig. 4. Breath 13CO2 output after consumption of 50 g rapidly hydro-
lysed (R) starch for healthy subjects (A; n 8) and for subjects with
type 2 diabetes (B; n 13). Values are means, with standard errors
of the mean represented by vertical bars. For details of subjects
and procedures, see Table 1 and p. 854.
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Table 5. Cumulative rates of carbohydrate and fat oxidation following consumption of test starches*
(Mean values and standard deviations)
Healthy subjects Diabetic subjects
50 g
R starch (n 8)
50 g
S starch (n 8)
50 g
R starch (n 13)
50 g
S starch (n 13)
89·7 g
S starch (n 10)
Mean SD Mean SD Mean SD Mean SD Mean SD
Total carbohydrate
oxidation (g/180 min)
35·3a 8·3 33·4a 8·0 39·3a 7·3 34·3b 6·8 34·6a,b 8·5
Total fat oxidation (g/180 min) 7·9a 4·2 8·9a 4·6 9·7a 2·7 11·4a 3·3 11·8a 3·3
a,bMean values with unlike subscript letters within a row, within each subject group, were significantly different (P,0·05).
* For details of subjects and procedures, see Table 1 and p. 854.
Fig. 5. (a), Change from baseline in total carbohydrate oxidation rate assessed by indirect calorimetry data after consumption of 50 g rapidly
hydrolysed (O) and 50 g slowly hydrolysed (B) starch for healthy subjects (n 8); (b), change from baseline in total carbohydrate oxidation rate
after consumption of 50 g rapidly hydrolysed starch (O; n 13), 50 g slowly hydrolysed starch (B; n 13) and a higher dose (89·7 g) of slowly
hydrolysed starch (A; n 11) for subjects with type 2 diabetes; (c), change from baseline in total fat oxidation rate after consumption of 50 g
rapidly hydrolysed (O) and 50 g slowly hydrolysed (B) starch for healthy subjects (n 8); (d), change from baseline in total fat oxidation rate
after consumption of 50 g rapidly hydrolysed starch (O; n 13), 50 g slowly hydrolysed starch (B; n 13) and a higher dose (89·7 g) of slowly
hydrolysed starch (A; n 11) for subjects with type 2 diabetes. Values are means, with standard errors of the mean represented by vertical
bars. For details of subjects and procedures, see Table 1 and p. 854.
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applicability of the GI approach to complex meals and
diets and across different population groups is debatable.
The authors of the present study have adopted a simple
in vitro hydrolysis procedure to predict the release of
glucose from starch products. Whilst it has yet to be
proven that this procedure can predict in vivo rates of
digestion of complex food mixtures, the results clearly
demonstrate that R and S starches have distinctly different
patterns of hydrolysis in vitro with characteristically
different patterns of postprandial glycaemia and insulinae-
mia when consumed in isolation as a single meal. The ratio
of glucose released after 180 min in vitro for R starch:S
starch was approximately 1·8:1 (Fig. 1), which compares
with a ratio of 1·5:1 and 1·9:1 for the 180 min IAUC or
1·9:1 and 1·8:1 for the maximum glucose change in the
healthy and type 2 volunteers, respectively (Table 3) as
measures of short-term glycaemic response in vivo. These
data suggest that the in vitro assay had good discriminatory
powers and has potential as a rapid screening method for
the evaluation of different starch products. However, the
behaviour of the starches when combined in a mixed
meal or incorporated into a processed food has yet to be
investigated.
The ratio of the IAUC for R starch:S starch in the dia-
betic subjects indicated that the more rapidly digested
starch produced nearly 80 % greater postprandial glycae-
mic response. Increasing the dose of the R starch to
89·7 g tested the hypothesis that providing 80 % more of
the slowly hydrolysed starch in the test drink would pro-
duce a plasma glucose response equal to that for the stan-
dard dose (50 g) of the R starch. While it was clear that the
bigger dose produced a greater response, the pattern of
change in blood glucose was quite different from that
with the R starch. Peak glucose concentration was
achieved much later and plasma glucose concentration
remained elevated above fasting levels for longer.
Although none of the outcome measures with the higher
dose of the S starch in the third experimental period was
Fig. 5. Continued
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statistically different from that for the R starch, it is unli-
kely that the higher dose of the S starch is metabolically
equivalent to the standard dose of the R starch in type 2
diabetics. The smaller than predicted plasma glucose
response with the higher dose of the S starch is consistent
with observations of a linear glycaemic dose–response for
intermediate GI foods delivering up to 50 g available
carbohydrate with a flattening of the response for doses
between 50 and 100 g (Wolever et al. 1991).
The measurement of expired 13CO2 has been used to
determine carbohydrate, lipid and amino acid oxidation
using both invasive infusion procedures and after the oral
consumption of substrates labelled with 13C (Seal, 1997).
In many studies, an exogenous label is used to enrich the
substrate pool (for example, see Daly et al. 2000), but
improved analytical techniques have resulted in the
increased use of substrates naturally enriched with
13C. Maize starch is naturally enriched due to the discrimi-
natory accumulation of the 13C molecule during CO2 fix-
ation in the C4-pathway for photosynthesis in the maize
plant (Hatch & Slack, 1966). Other C-containing biomole-
cules (including protein) in the maize plant will similarly
be enriched following the redistribution of fixed
13C. However, in the present experiment, the contribution
of these components to 13CO2 output will be negligible
due to the high purity of the test starches. [13C]Glucose
released during the hydrolysis of maize starch is absorbed
and its subsequent oxidation results in the production
of 13CO2 in breath. Measurement of the appearance of
labelled glucose in blood shows that the pattern of
[13C]glucose in blood is very different to the glycaemic
response determined by the measurement of total blood
glucose (Normand et al. 1992). Measuring breath 13CO2
output compares with measurements of the appearance of
[13C]glucose in blood (Normand et al. 1992), and can,
therefore, be used to estimate rates of glucose absorption
and oxidation. The data of Normand et al. (1992), and
the results from the present study, show that glucose
absorption following a starchy meal continues well after
the insulin response has resulted in the return of blood glu-
cose concentrations to fasting levels and that oxidation of
the absorbed glucose continues for several hours after the
meal. Daly et al. (2000) have also used this method to
quantify rates of carbohydrate oxidation using uniformly
labelled [13C]fructose and [13C]glucose and demonstrated
different rates of oxidation of the two sugars following
high-starch and high-sucrose meals. It is probable that
the pattern of rate of 13CO2 output is closely related to
the pattern of uptake of glucose from the gut, albeit
delayed whilst the postprandial insulin surge shuts down
lipolysis and cells switch to glucose as the main oxidizable
fuel. The sustained use of glucose as the oxidizable fuel is
also confirmed by the lower circulating concentrations of
3-hydroxybutyrate and NEFA at the end of the study
period following consumption of the S starch, especially
after the higher dose consumed in the third experimental
period by the diabetic subjects. For the R starch, the rate
of 13CO2 output was lower for the diabetics than for the
healthy subjects until 280 min after which time the rate
of output fell faster for the healthy subjects. This may
be a consequence of the reduced insulin sensitivity in
diabetics which delayed the entry of glucose into cells
and led to the slightly lower recovery of administered
13C as 13CO2.
For the R starch only, approximately 5–7 % of the 13C
dose was recovered after 180 min and this increased at a
linear rate, reaching 24–28 % by the end of the 6 h study
period, confirming the prolonged metabolism of the labelled
exogenous glucose long after the plasma glycaemic
response had ended. Over a slightly longer time period of
8 h, Achour et al. (1997) recovered approximately 30 % of
13C from a 50 g dose of naturally-enriched maize starches
in breath. This group also showed that the recovery of 13C
was lower for a partially indigestible (retrograded) maize
starch compared with a digestible (pre-gelatinized) product.
Their study confirms the usefulness of the 13C methodology
in investigating the metabolic effects of consuming modi-
fied starches in addition to the observations for raw products
described in the present experiment.
The long-term benefits of reducing the rate of glucose
absorption with the use of slowly digested starches
(expected to have lower GI) include greater glycaemic
control in subjects with diabetes or metabolic syndrome
and lowered NEFA concentrations in patients with hyper-
triacylglycerolaemia (Food and Agriculture Organization/
World Health Organization, 1998; Wolever, 2000). There
may also be benefits in healthy individuals by reducing
postprandial fatty acids concentrations (Wolever et al.
1995) and in preventing the development of type 2 dia-
betes and cardiovascular disease (Salmero´n et al.
1997a,b; Frost et al. 1998, 1999). The results from the
present study show that starches with contrasting
hydrolysis characteristics in vitro have correspondingly
different postprandial glycaemic and insulinaemic
responses in both healthy volunteers and type 2 diabetic
subjects. Based on the appearance of 13CO2 in breath,
there was strong evidence that the oxidation of exogen-
ous glucose continued at high rates long after the
plasma glycaemia had returned to fasting levels. These
observations reinforce the utility of 13CO2 tracking as a
simple quantitative procedure for characterizing the rate
and extent of starch digestion and glucose disposal
through oxidation.
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